Incyte

American pharmaceutical company

INCY Nasdaq ISIN US45337C1027 SEC CIK 879169 LEI 549300Z4WN6JVZ3T4680
Follow Incyte Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.6B +14% vs same quarter last year
Net income −$784.8M −285% vs same quarter last year
EPS, diluted −$3.86 −282.9% vs same quarter last year
Operating cash flow −$675.3M −220.7% vs same quarter last year
Revenue by quarter
$1.2B
$1.1B
$1.2B
$1.4B
$1.5B
$1.3B
$1.7B
$1.6B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$2B$0$2B$4B$6BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$5.1B$1.3B
FY24$4.2B$32.6M
FY23$3.7B$597.6M
FY22$3.4B$340.7M
FY21$3B$948.6M
FY20$2.7B−$295.7M
FY19$2.2B$446.9M
FY18$1.9B$109.5M
FY17$1.5B−$313.1M
FY16$1.1B$104.2M
FY15$753.8M$6.5M
FY14$511.5M−$48.5M
FY13$354.9M−$83.1M
FY12$297.1M−$44.3M
FY11$94.5M−$186.5M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2592.8%29.5%25%
FY2492.6%1.4%0.8%
FY2393.1%16.8%16.2%
FY2293.9%17.1%10%
FY2194.9%19.6%31.8%
FY2095.1%−9.9%−11.1%
FY1994.7%18.6%20.7%
FY1895%6.9%5.8%
FY1794.8%−15.8%−20.4%
FY1694.7%13.1%9.4%
FY1596.4%6.7%0.9%
FY1499.4%−0.9%−9.5%
FY1399.8%−4.5%−23.4%
FY1299.9%0.4%−14.9%
FY11-−151.6%−197.5%
Free cash flowOperating cash flow minus capital expenditure
−$500M$0$500M$1BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22$892.1M
FY21$568.5M
FY20−$312M
FY19$632.6M
FY18$262.7M
FY17−$204M
FY16$184.5M
FY15$63.4M
FY14−$1.6M
FY13$4.9M
FY12−$97.7M
FY11−$165.5M
Returned to shareholdersDividends paid and shares bought back
$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$0
FY24$2B
FY23$0
FY22$0
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Incyte
  • Healthcare median
−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearIncyteHealthcare median
FY2525%−30.6%
FY240.8%−47%
FY2316.2%−58%
FY2210%−80.4%
FY2131.8%−71.9%
FY20−11.1%−62.2%
FY1920.7%−46.3%
FY185.8%−49.6%
FY17−20.4%−45.9%
FY169.4%−36%
FY150.9%−38.4%
FY14−9.5%−35.5%
FY13−23.4%−37.1%
FY12−14.9%−29.1%
FY11−197.5%−27.9%